VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
-5.48%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$97.2M
AUM Growth
+$97.2M
(-16%)
Cap. Flow
+$17.2M
Cap. Flow
% of AUM
17.74%
Top 10 Holdings %
Top 10 Hldgs %
76.66%
Holding
55
New
10
Increased
17
Reduced
2
Closed
8
Top Buys
| 1 |
SLRN
ACELYRIN
SLRN
|
$8.32M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$2.86M |
| 3 |
Zevra Therapeutics
ZVRA
|
$2.73M |
| 4 |
scPharmaceuticals
SCPH
|
$2.41M |
| 5 |
Mineralys Therapeutics
MLYS
|
$2.39M |
Top Sells
| 1 |
Praxis Precision Medicines
PRAX
|
$4.36M |
| 2 |
Nurix Therapeutics
NRIX
|
$1.84M |
| 3 |
Kura Oncology
KURA
|
$1.31M |
| 4 |
Rezolute
RZLT
|
$1.16M |
| 5 |
Collegium Pharmaceutical
COLL
|
$822K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Karyopharm Therapeutics
KPTI
$61.4M
| – | – |
-40,000
| Closed | -$27.1K |
|
|
52
Kura Oncology
KURA
$732M
| – | – |
-150,000
| Closed | -$1.31M |
|
|
53
Nurix Therapeutics
NRIX
$723M
| – | – |
-97,889
| Closed | -$1.84M |
|
54
Bolt Biotherapeutics
BOLT
$9.29M
| – | – |
-50,000
| Closed | -$26.8K |
|
55
Cocrystal Pharma
COCP
$15M
| – | – |
-10,000
| Closed | -$20.2K |
|